The iconic rise of Viagra has consistently remained a symbol of pharmaceutical success, however its legacy within the broader market now raises questions about future returns . Generic versions are eroding patent protection , prompting anxieties that investing in companies significantly dependent to Viagra's previous position could be a speculative